4//SEC Filing
Ali Asif 4
Accession 0001104659-24-030156
CIK 0001377121other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 8:45 PM ET
Size
14.5 KB
Accession
0001104659-24-030156
Insider Transaction Report
Form 4
Ali Asif
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-02-29$30.61/sh−7,850$240,289→ 42,734 total - Sale
Common Stock
2024-02-29$31.00/sh−2,089$64,759→ 40,645 total - Exercise/Conversion
Common Stock
2024-03-01$12.17/sh+12,000$146,040→ 52,645 total - Sale
Common Stock
2024-03-01$32.22/sh−12,000$386,640→ 40,645 total - Sale
Common Stock
2024-03-01$32.33/sh−2,248$72,678→ 38,397 total - Exercise/Conversion
Stock Option (right to buy)
2024-03-01−12,000→ 51,750 totalExercise: $12.17Exp: 2033-01-15→ Common Stock (12,000 underlying)
Footnotes (4)
- [F1]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $30.57 to $30.76. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $32.17 to $32.31. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $32.28 to $32.39. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F4]The stock option was granted to the Reporting Person on January 16, 2023 and vests in 48 equal monthly installments following the date of grant.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001921163
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 8:45 PM ET
- Size
- 14.5 KB